EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease Inhibitors

Nina Geiger iD, Viktoria Diesendorf, Valeria Roll, Eva-Maria König, Helena Obernolte, Katherina Sewald iD, Julian Breidenbach iD, Thanigaimalai Pillaiyar iD, Michael Gütschow iD, Christa E Müller iD, Jochen Bodem iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24043972 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Nina Geiger und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Virology and Immunobiology, University of Würzburg, Versbacher Strasse 7, 97078 Würzburg, Germany. Hauptthemen laut MEDLINE: COVID-19, Hepatitis C, Chronic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Volkswagen Foundation, Open Access Publication Fund of the University of Würzburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, we have described novel pyridyl indole esters and peptidomimetics as potent inhibitors of the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) main protease. Here, we analysed the impact of these compounds on viral replication. It has been shown that some antivirals against SARS-CoV-2 act in a cell line-specific way. Thus, the compounds were tested in Vero, Huh-7, and Calu-3 cells. We showed that the protease inhibitors at 30 µM suppress viral replication by up to 5 orders of magnitude in Huh-7 cells, while in Calu-3 cells, suppression by 2 orders of magnitude was achieved. Three pyridin-3-yl indole-carboxylates inhibited viral replication in all cell lines, indicating that they might repress viral replication in human tissue as well. Thus, we investigated three compounds in human precision-cut lung slices and observed donor-dependent antiviral activity in this patient-near system. Our results provide evidence that even direct-acting antivirals may act in a cell line-specific manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Hepatitis C, ChronicHumansAntiviral AgentsSARS-CoV-2Protease InhibitorsIndolesCoronavirus 3C Proteases

Stichwörter der Autor:innen

SARS-CoV-2azapeptide nitrilescell line specificity pyridyl indole carboxylatespeptidomimeticsprotease inhibitors

Substanzen

Antiviral AgentsProtease InhibitorsIndoles3C-like proteinase, SARS-CoV-2Coronavirus 3C Proteases

Autor:innen und Institutionen

  • Institute for Virology and Immunobiology, University of Würzburg, Versbacher Strasse 7, 97078 Würzburg, Germany.
  • Member of DZL, BREATH and iCAIR, 30625 Hannover, Germany.
  • Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry University of Bonn, An der Immenburg 4, 53121 Bonn, Germany.

ORCID-Profile: Nina Geiger, Katherina Sewald, Julian Breidenbach, Thanigaimalai Pillaiyar, Michael Gütschow, Christa E Müller, Jochen Bodem

Förderung

  • Volkswagen Foundation
  • Open Access Publication Fund of the University of Würzburg

Zitieren

APA

Geiger, N., Diesendorf, V., Roll, V., König, E. M., Obernolte, H., Sewald, K., Breidenbach, J., Pillaiyar, T., Gütschow, M., Müller, C. E., & Bodem, J. (2023). Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease Inhibitors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043972

Vancouver

Geiger N, Diesendorf V, Roll V, König EM, Obernolte H, Sewald K, et al. Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease Inhibitors. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043972

BibTeX
@article{Geiger2023,
  author = {Geiger, Nina and Diesendorf, Viktoria and Roll, Valeria and König, Eva-Maria and Obernolte, Helena and Sewald, Katherina and Breidenbach, Julian and Pillaiyar, Thanigaimalai and Gütschow, Michael and Müller, Christa E and Bodem, Jochen},
  title = {Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease Inhibitors},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24043972}
}
Kostenlos starten →